A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors
Clinical trial NCT02663518 · TERMINATED
Trial details
- NCT number
- NCT02663518
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-28
- Primary completion
- 2022-11-23
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.